Moment's $78M Series C: NYC AI OS for Advisors Managing $10T+ in Client Assets
Moment raised $78M led by Index Ventures — AI operating system deployed at Edward Jones, LPL, and Hightower collectively overseeing $10T+.
NYC Startups, Venture Capital & Funding News
New York City is the third-largest venture capital hub in the U.S., with deep strength in fintech, enterprise software, media, and AI. Our NYC startup coverage tracks funding rounds, emerging unicorns, and the investors shaping the city's tech ecosystem.
NYC Startup Ecosystem Highlights
- Top sectors: Fintech, B2B SaaS, healthtech, and consumer applications
- Active investors: Union Square Ventures, Thrive Capital, Insight Partners, and emerging managers
- Deal activity: Quarterly roundups and firm-by-firm fund news
- Ecosystem data: Valuations, unicorn counts, and sector comparisons vs. SF
Explore NYC startup articles to research investors and track funding in New York.
Related Articles (87 articles)
-
-
Eisen's $18.5M: NYC Regtech Bets That Compliance Ops Should Run Like Software
Eisen raised $18.5M including a $10M Series A for AI-enabled compliance operations — escheatment, disbursements, and 1099 workflows automated.
-
Status AI's $17M: NYC-Backed Bet That Social's Next Chapter Isn't Another Feed
Status AI raised $17M seed + Series A from USV, GC, and YC — 13M worlds created as gamified social entertainment replaces passive scrolling.
-
Relay's $50M From General Catalyst: NYC SMB Banking Still Has Room to Win
Relay secured $50M growth investment for small business banking and money management — a signal that SMB fintech isn't a solved category.
-
Checker's $8M: NYC Stablecoin Orchestration for Banks That Can't Wait on Fragmented Rails
Checker raised $8M led by Galaxy Ventures — a single API for FIs to plug into stablecoin liquidity, cross-border payments, and compliance.
-
Century Health's $5M Seed: 97% Clinical Abstraction Accuracy Is the Headline That Matters
Century Health raised $5M seed in NYC — CHARM model hits 97% accuracy on clinical data abstraction for life sciences R&D.